FRES

Fresh2

1.98 USD
+0.45
29.41%
At close Oct 17, 4:00 PM EDT
After hours
1.95
-0.03
1.52%
1 day
29.41%
5 days
41.43%
1 month
26.11%
3 months
-23.55%
6 months
-43.43%
Year to date
-72.27%
1 year
-69.54%
5 years
-99.91%
 

About: Fresh2 Group Ltd is a biotechnology company. It focuses on early cancer screening and detection. The company markets and sells a multi-cancer screening and detection test that uses its innovative patented CDA technology and its proprietary CDA device. In addition to early cancer screening and detection, its CDA technology has demonstrated the potential to assist physicians in cancer diagnosis, prognosis, and recurrence.

Employees: 75

0
Funds holding %
of 6,740 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

491% more capital invested

Capital invested by funds: $3.67K [Q1] → $21.7K (+$18K) [Q2]

200% more funds holding

Funds holding: 1 [Q1] → 3 (+2) [Q2]

0.01% more ownership

Funds ownership: 0% [Q1] → 0.01% (+0.01%) [Q2]

Research analyst outlook

We haven’t received any recent analyst ratings for FRES.

Financial journalist opinion

Charts implemented using Lightweight Charts™